Cetuximab: a review of its use in squamous cell carcinoma of the head and neck

JE Frampton - Drugs, 2010 - Springer
Cetuximab (Erbitux®) is a chimeric monoclonal antibody directed against the human
epidermal growth factor receptor (EGFR). EGFR is overexpressed and/or upregulated in …

Cetuximab: a review of its use in squamous cell carcinoma of the head and neck

JE Frampton - Drugs, 2010 - pubmed.ncbi.nlm.nih.gov
Cetuximab (Erbitux®) is a chimeric monoclonal antibody directed against the human
epidermal growth factor receptor (EGFR). EGFR is overexpressed and/or upregulated in …

[引用][C] Cetuximab

JE Frampton - Drugs, 2010 - cir.nii.ac.jp
Cetuximab | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動
検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士論文をさがす …

Cetuximab: a review of its use in squamous cell carcinoma of the head and neck.

JE Frampton - Drugs, 2010 - europepmc.org
Cetuximab (Erbitux®) is a chimeric monoclonal antibody directed against the human
epidermal growth factor receptor (EGFR). EGFR is overexpressed and/or upregulated in …

[引用][C] Cetuximab: A Review of its Use in Squamous Cell Carcinoma of the Head and Neck

JE FRAMPTON - Drugs (Basel), 2010 - pascal-francis.inist.fr
Cetuximab: A Review of its Use in Squamous Cell Carcinoma of the Head and Neck CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …

Cetuximab

JE Frampton - Drugs, 2010 - infona.pl
Cetuximab (Erbitux®) is a chimeric monoclonal antibody directed against the human
epidermal growth factor receptor (EGFR). EGFR is overexpressed and/or upregulated in …

Cetuximab: a review of its use in squamous cell carcinoma of the head and neck

JE Frampton - Drugs, 2010 - go.gale.com
Cetuximab (Erbitux [R]) is a chimeric monoclonal antibody directed against the human
epidermal growth factor receptor (EGFR). EGFR is overexpressed and/or upregulated in …

Cetuximab

JE Frampton - Drugs, 2010 - search.proquest.com
Cetuximab (Erbitux®) is a chimeric monoclonal antibody directed against the human
epidermal growth factor receptor (EGFR). EGFR is overexpressed and/or upregulated in …

[引用][C] Cetuximab: A Review of its Use in Squamous Cell Carcinoma of the Head and Neck (Adis Drug Evaluation)

JE Frampton - Drugs, 2010 - Adis International